Last reviewed · How we verify
Radix/Rhizoma Notoginseng Extract (Sanchitongtshu) Plus Asprine for Minor Ischemic Stroke or Transient Ischemic Attack: A Randomized Double-blind Placebo-controlled Study
Agents of sanchi have been widely used as a complementary medicine for stroke in China. Sanchitongshu is a new Chinese patent medicine extracted from sanchi which has stronger anti-platelet activity than other agents of sanchi. The investigators's aim was to investigate the synergistic action of aspirin combined with sanchitongshu capsule in the treatment of patients with minor ischemic stroke and transient ischemic attack.
Details
| Lead sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 120 |
| Start date | 2016-12 |
| Completion | 2019-11 |
Conditions
- Stroke, Acute
- Ischemic Attack, Transient
Interventions
- Sanchitongshu
- placebo of Sanchitongshu
- Aspirin
- Clopidogrel
- placebo of clopidogrel
Primary outcomes
- Percentage of patients with the180-day new vascular events, defined as any event of the following: Any stroke (ischemic or hemorrhage) — 180 days